speb/financial-data huggingface dataset:
Financial ratios for WAK.AX — annual report dated 2022-06-30
Total revenue: 808808.275862069
Gross profit: 198287.58620689655
Operating income: -4104192.413793104
Net income: -5207771.724137931
Capital expenditures: 7467651.0344827585
Depreciation & amortization: 199335.1724137931
Net tangible assets: 3769048.275862069
Owner earnings: -12476087.586206896
Return on net tangible assets (%): -331.0142686711362
Buffett classification: The Gruesome
Stock price: 0.13793103448275862
Shares outstanding: 1396356838
Book value: 3993382.068965517
P/B ratio: 48.230031548748585
Market cap (USD): 192600943.1724138
Debt to equity: 4.201910954745127
Current ratio: 2.573379028509858
Quick ratio: 2.362856731115189
Interest coverage ratio: -3.0581681451128033
COGS to revenue (%): 75.48398154116911
R&D to revenue (%): 3.989351723949753
SG&A to revenue (%): 400.5690790707828
Free cash flow (dilution-adjusted): -10504757.241379311
Buyback yield (%): 0
Retained earnings: -50155262.758620694
Inventory turnover: 1.3377200935680997
Receivables turnover: 1.4348678270189323
Capitalized R&D asset: 46353.83847549909
ROCI (R&D-adjusted, %): -19.75798653800642
Rosenberg metric: 0.06785230306355909
FCF margin (%): -1298.7944800864962
Revenue growth (%): -11.071769305965077
Rule of 40 score: -1309.8662493924612
Financial ratios for WAK.AX — annual report dated 2023-06-30
Total revenue: 966693.3774834437
Gross profit: 405805.29801324505
Operating income: -1036803.3112582781
Net income: -2483338.4105960266
Capital expenditures: 4665200.662251656
Depreciation & amortization: 297325.8278145695
Net tangible assets: 6490390.728476821
Owner earnings: -6851213.245033113
Return on net tangible assets (%): -105.55933427818405
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 1396356838
Book value: 7392658.278145697
P/B ratio: 16.261559386733605
Market cap (USD): 120216151.61589403
Debt to equity: 2.640492437727281
Current ratio: 0.42924223264615013
Quick ratio: 0.2400872479107029
Interest coverage ratio: -0.5904689813630957
COGS to revenue (%): 58.0213015351711
R&D to revenue (%): 1.6517698414818864
SG&A to revenue (%): 3.0135499795506906
Free cash flow (dilution-adjusted): -7413771.523178807
Buyback yield (%): 0
Retained earnings: -50645676.821192056
Inventory turnover: 0.2560579922566539
Receivables turnover: 1.8175724809116582
Capitalized R&D asset: 44524.59250009014
ROCI (R&D-adjusted, %): -5.766164854536618
Rosenberg metric: 6.431425685444477
FCF margin (%): -766.9206902481113
Revenue growth (%): 19.520707976571178
Rule of 40 score: -747.3999822715401
Financial ratios for WAK.AX — annual report dated 2024-06-30
Total revenue: 1717214
Gross profit: -866004.6666666666
Operating income: -8617918
Net income: -9053790
Capital expenditures: 3221454.6666666665
Depreciation & amortization: 615581.3333333334
Net tangible assets: 3980331.3333333335
Owner earnings: -11659663.333333332
Return on net tangible assets (%): -292.93197869457094
Buffett classification: The Gruesome
Stock price: 0.02666666666666667
Shares outstanding: 1396356838
Book value: 3980331.333333336
P/B ratio: 9.355045906563552
Market cap (USD): 37236182.34666667
Debt to equity: 4.262377989638046
Current ratio: 0.2127455403496089
Quick ratio: 0.0850015914885277
Interest coverage ratio: -8.845500945321872
COGS to revenue (%): 150.43079468643202
R&D to revenue (%): 3.0606552241013643
SG&A to revenue (%): 192.81141818472634
Free cash flow (dilution-adjusted): -9042901.333333334
Buyback yield (%): 0
Retained earnings: -60037104.666666664
Inventory turnover: 1.2212056087814727
Receivables turnover: 2.394121539854298
Capitalized R&D asset: 73904.10655400777
ROCI (R&D-adjusted, %): -108.38007928382609
Rosenberg metric: -79.64966391550192
FCF margin (%): -526.6030519977902
Revenue growth (%): 77.63791911664464
Rule of 40 score: -448.96513288114556
Financial ratios for ZFR.V — annual report dated 2021-12-31
Capital expenditures: 340259.84251968504
Buffett classification: The Gruesome
Stock price: 0.12598425196850394
Shares outstanding: 93286985
Market cap (USD): 11752691.023622047
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZFR.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -522549.99999999994
Net income: -566780.1470588235
Capital expenditures: 29854.41176470588
Operating cash flow: -367966.1764705882
Net tangible assets: 4971938.970588235
Owner earnings: -596634.5588235294
Return on net tangible assets (%): -12.000037859534325
Buffett classification: The Gruesome
Stock price: 0.06617647058823528
Shares outstanding: 93286985
Book value: 4971938.970588235
P/B ratio: 1.2416490740607913
Market cap (USD): 6173403.419117646
Debt to equity: 0
Current ratio: 8.037832814989
Quick ratio: 8.037832814989
Free cash flow (dilution-adjusted): -612491.1764705882
Buyback yield (%): 0
Retained earnings: -4428125.735294118
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.3577362014881
Rule of 40 score: 0
Financial ratios for ZFR.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -430484.0909090909
Net income: -1575962.121212121
Capital expenditures: 0
Operating cash flow: -354130.30303030304
Net tangible assets: 3873925.7575757573
Owner earnings: -1575962.121212121
Return on net tangible assets (%): -40.68126804263626
Buffett classification: The Gruesome
Stock price: 0.06060606060606061
Shares outstanding: 93286985
Book value: 3873925.7575757573
P/B ratio: 1.4594385696758165
Market cap (USD): 5653756.666666667
Debt to equity: 0
Current ratio: 2.144356627409328
Quick ratio: 2.144356627409328
Free cash flow (dilution-adjusted): -544066.6666666666
Buyback yield (%): 0
Retained earnings: -6138273.484848484
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.901043086475482
Rule of 40 score: 0
Financial ratios for ZFR.V — quarterly report dated 2024-09-30
Capital expenditures: 10737.037037037036
Buffett classification: The Gruesome
Stock price: 0.037037037037037035
Shares outstanding: 93286985
Market cap (USD): 3455073.518518518
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZFR.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -30976.923076923078
Net income: -30304.195804195806
Capital expenditures: 0
Operating cash flow: -34759.44055944056
Net tangible assets: 3590416.7832167833
Owner earnings: -30304.195804195806
Return on net tangible assets (%): -0.8440300286543667
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 93286985
Book value: 3590416.7832167833
P/B ratio: 0.7267752774674464
Market cap (USD): 2609426.153846154
Debt to equity: 0.004987051778861211
Current ratio: 1.5851072900383685
Quick ratio: 1.5851072900383685
Free cash flow (dilution-adjusted): -89302.09790209791
Buyback yield (%): 0
Retained earnings: -5788677.622377623
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8412571321786123
Rule of 40 score: 0
Financial ratios for ZFR.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -123208.39160839161
Net income: -122579.02097902098
Capital expenditures: 0
Operating cash flow: -97256.64335664336
Net tangible assets: 3590416.7832167833
Owner earnings: -122579.02097902098
Return on net tangible assets (%): -3.4140610514080216
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 93286985
Book value: 3590416.7832167833
P/B ratio: 0.7267752774674464
Market cap (USD): 2609426.153846154
Debt to equity: 0.004987051778861211
Current ratio: 1.5851072900383685
Quick ratio: 1.5851072900383685
Free cash flow (dilution-adjusted): -101732.16783216783
Buyback yield (%): 0
Retained earnings: -5788677.622377623
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.3460372396389224
Rule of 40 score: 0
Financial ratios for ZFR.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -24634.965034965036
Net income: -24861.53846153846
Capital expenditures: 0
Operating cash flow: -29146.153846153848
Net tangible assets: 3565555.244755245
Owner earnings: -24861.53846153846
Return on net tangible assets (%): -0.6972697589837811
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 93286985
Book value: 3565555.2447552453
P/B ratio: 0.5488821462697479
Market cap (USD): 1957069.6153846155
Debt to equity: 0.005021824982780072
Current ratio: 0.9456636900257303
Quick ratio: 0.9456636900257303
Free cash flow (dilution-adjusted): -29146.153846153848
Buyback yield (%): 0
Retained earnings: -5813539.160839161
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6735851852560027
Rule of 40 score: 0
Financial ratios for ZFR.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -99200.7299270073
Net income: -100625.54744525546
Capital expenditures: 0
Operating cash flow: -52491.24087591241
Net tangible assets: 3691158.3941605836
Owner earnings: -100625.54744525546
Return on net tangible assets (%): -2.726123799088253
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 93286985
Book value: 3691158.3941605836
P/B ratio: 0.9223756136927718
Market cap (USD): 3404634.4890510947
Debt to equity: 0.014950897656997279
Current ratio: 0.25926602949113003
Quick ratio: 0.25926602949113003
Free cash flow (dilution-adjusted): -132002.1897810219
Buyback yield (%): 0
Retained earnings: -6168772.262773722
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.622289411762436
Rule of 40 score: 0
Financial ratios for ZFR.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -18678.41726618705
Net income: -34729.4964028777
Capital expenditures: 114779.13669064749
Operating cash flow: 23933.81294964029
Net tangible assets: 3786374.820143885
Owner earnings: -149508.6330935252
Return on net tangible assets (%): -3.9485956936467206
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 93286985
Book value: 3786374.820143885
P/B ratio: 0.8862426732276142
Market cap (USD): 3355646.9424460437
Debt to equity: 0.004865039565378399
Current ratio: 1.0159741822051542
Quick ratio: 1.0159741822051542
Free cash flow (dilution-adjusted): -90845.3237410072
Buyback yield (%): 0
Retained earnings: -6114743.165467626
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.47835456200977083
Rule of 40 score: 0
Financial ratios for ZLAB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 62.85
Shares outstanding: 112922546
Market cap (USD): 7097182016.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZLAB — annual report dated 2022-12-31
Total revenue: 33962212.64367816
Gross profit: 20261781.609195404
Operating income: -56449137.93103448
Net income: -63690517.24137931
Capital expenditures: 3532327.5862068967
Operating cash flow: -52822126.43678161
Depreciation & amortization: 1182040.2298850575
Net tangible assets: 149021839.08045977
Owner earnings: -66040804.597701155
Return on net tangible assets (%): -44.31619218042561
Buffett classification: The Gruesome
Stock price: 30.7
Shares outstanding: 112922546
Book value: 150229166.66666666
P/B ratio: 23.07622573645819
Market cap (USD): 3466722162.2
Debt to equity: 0.019503727542691005
Current ratio: 8.040045193861644
Quick ratio: 7.813925716165388
COGS to revenue (%): 31.313537273084947
R&D to revenue (%): 121.16576485867914
SG&A to revenue (%): 109.55845957940072
Free cash flow (dilution-adjusted): -65219540.22988506
Buyback yield (%): 0
Retained earnings: -267436781.6091954
Inventory turnover: 2.3407861863951167
Receivables turnover: 4.866628234955014
Capitalized R&D asset: 41150574.712643676
ROCI (R&D-adjusted, %): -14.776208879841993
FCF margin (%): -192.03560414084282
Rule of 40 score: -192.03560414084282
Financial ratios for ZLAB — annual report dated 2023-12-31
Total revenue: 42040928.270042196
Gross profit: 24036990.15471167
Operating income: -52621659.63431786
Net income: -47063291.1392405
Capital expenditures: 449648.38255977497
Operating cash flow: -27873136.427566808
Depreciation & amortization: 1269901.5471167369
Net tangible assets: 109656821.37834036
Owner earnings: -46243037.974683546
Return on net tangible assets (%): -42.17068978785625
Buffett classification: The Gruesome
Stock price: 27.33
Shares outstanding: 112922546
Book value: 111971589.31082982
P/B ratio: 27.562109291964003
Market cap (USD): 3086173182.18
Debt to equity: 0.01903109840501031
Current ratio: 4.627073822925438
Quick ratio: 4.406324021135881
COGS to revenue (%): 32.055026412544194
R&D to revenue (%): 88.94553897313916
SG&A to revenue (%): 94.21132042648145
Free cash flow (dilution-adjusted): -40267651.19549929
Buyback yield (%): 0
Retained earnings: -308857946.5541491
Inventory turnover: 2.1374617975773527
Receivables turnover: 4.575191710161787
Capitalized R&D asset: 64964415.29657112
ROCI (R&D-adjusted, %): -22.733059000623047
Rosenberg metric: 0.0917413322141603
FCF margin (%): -95.78202207345998
Revenue growth (%): 23.787365420279343
Rule of 40 score: -71.99465665318064
Financial ratios for ZLAB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.14
Shares outstanding: 112922546
Market cap (USD): 2725950260.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZLAB — annual report dated 2024-12-31
Total revenue: 58250547.94520548
Gross profit: 34401095.89041096
Operating income: -37526986.30136986
Net income: -35219589.04109589
Capital expenditures: 770958.904109589
Operating cash flow: -29434109.589041095
Depreciation & amortization: 1624109.589041096
Net tangible assets: 107118356.16438356
Owner earnings: -34366438.35616438
Return on net tangible assets (%): -32.08267899801014
Buffett classification: The Gruesome
Stock price: 26.19
Shares outstanding: 112922546
Book value: 115191506.84931508
P/B ratio: 25.674127899105482
Market cap (USD): 2957441479.7400002
Debt to equity: 0.18250846119267733
Current ratio: 3.508793025702691
Quick ratio: 3.37560332013962
Interest coverage ratio: -121.53815439219164
COGS to revenue (%): 34.77185234309042
R&D to revenue (%): 55.14769688802974
SG&A to revenue (%): 70.25414541341254
Free cash flow (dilution-adjusted): -47540000
Buyback yield (%): 0
Retained earnings: -336038767.1232877
Inventory turnover: 3.708087774294671
Receivables turnover: 4.75589133328114
Capitalized R&D asset: 70757190.53180768
ROCI (R&D-adjusted, %): -22.006984178255827
Rosenberg metric: 0.27716307258046075
FCF margin (%): -81.61296618998234
Revenue growth (%): 38.556759667730844
Rule of 40 score: -43.0562065222515
Financial ratios for ZLAB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.19
Shares outstanding: 112922546
Market cap (USD): 2957441479.7400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZLAB — quarterly report dated 2025-03-31
Total revenue: 15588154.269972453
Gross profit: 9344352.61707989
Operating income: -7754132.231404959
Net income: -6671900.826446281
Capital expenditures: 211294.76584022038
Operating cash flow: -8498484.84848485
Depreciation & amortization: 476308.5399449036
Net tangible assets: 103536225.89531681
Owner earnings: -6406887.052341597
Return on net tangible assets (%): -6.188063160443437
Buffett classification: The Gruesome
Stock price: 36.14
Shares outstanding: 112922546
Book value: 111673966.94214877
P/B ratio: 36.544065946489745
Market cap (USD): 4081020812.44
Debt to equity: 0.23718444458423216
Current ratio: 3.257802362049611
Quick ratio: 3.0919085573486504
Interest coverage ratio: -47.42628475147431
COGS to revenue (%): 34.149509587346465
R&D to revenue (%): 53.661747813024654
SG&A to revenue (%): 56.041353715649024
Free cash flow (dilution-adjusted): -11207438.016528927
Buyback yield (%): 0
Retained earnings: -344562121.21212125
Inventory turnover: 0.728446488483432
Receivables turnover: 1.290819294423597
Capitalized R&D asset: 8364876.033057852
ROCI (R&D-adjusted, %): -1.729173138259473
FCF margin (%): -71.89714588671909
Rule of 40 score: -71.89714588671909
Financial ratios for ZLAB — quarterly report dated 2025-06-30
Total revenue: 16376847.977684798
Gross profit: 9310599.721059972
Operating income: -7119246.8619246865
Net income: -5680195.258019526
Capital expenditures: 395676.429567643
Operating cash flow: -4326917.712691771
Depreciation & amortization: 520920.5020920502
Net tangible assets: 102141701.53417015
Owner earnings: -5554951.185495118
Return on net tangible assets (%): -5.438475277051051
Buffett classification: The Gruesome
Stock price: 34.97
Shares outstanding: 112922546
Book value: 110423291.49232915
P/B ratio: 35.76148999230222
Market cap (USD): 3948901433.62
Debt to equity: 0.24174755442161835
Current ratio: 3.1193329733545303
Quick ratio: 2.933209854570575
Interest coverage ratio: -40.44770206022187
COGS to revenue (%): 36.80741258026605
R&D to revenue (%): 43.10435863807464
SG&A to revenue (%): 60.49803273662516
Free cash flow (dilution-adjusted): -7276150.6276150625
Buyback yield (%): 0
Retained earnings: -354567364.0167364
Inventory turnover: 0.700486223662885
Receivables turnover: 1.1819975438384571
Capitalized R&D asset: 12663602.22806229
ROCI (R&D-adjusted, %): -4.038820305271754
Rosenberg metric: -0.004035074266077117
FCF margin (%): -44.42949362129754
Revenue growth (%): 5.059570838554054
Rule of 40 score: -39.36992278274349
Financial ratios for ZLAB — quarterly report dated 2025-09-30
Total revenue: 17954634.831460673
Gross profit: 9720786.516853932
Operating income: -6737078.651685393
Net income: -5050983.146067415
Capital expenditures: 416853.93258426967
Operating cash flow: -4500561.797752809
Depreciation & amortization: 547893.2584269663
Net tangible assets: 98569522.4719101
Owner earnings: -4919943.820224719
Return on net tangible assets (%): -4.991343872672998
Buffett classification: The Gruesome
Stock price: 33.89
Shares outstanding: 112922546
Book value: 106733848.31460673
P/B ratio: 35.855027663387226
Market cap (USD): 3826945083.94
Debt to equity: 0.2886551000401345
Current ratio: 2.8711423163196383
Quick ratio: 2.684536466454864
Interest coverage ratio: -34.26285714285714
COGS to revenue (%): 36.67404585526882
R&D to revenue (%): 37.491493073210414
SG&A to revenue (%): 54.84014800096998
Free cash flow (dilution-adjusted): -7451264.044943821
Buyback yield (%): 0
Retained earnings: -362108286.5168539
Inventory turnover: 0.6983391673493707
Receivables turnover: 1.2174372648921479
Capitalized R&D asset: 14221490.406628458
ROCI (R&D-adjusted, %): -5.844145174688178
Rosenberg metric: 0.058107229735699456
FCF margin (%): -41.50050454876132
Revenue growth (%): 9.634252304996533
Rule of 40 score: -31.866252243764787
Financial ratios for ZLAB — annual report dated 2025-12-31
Total revenue: 71315142.85714285
Gross profit: 38439285.71428572
Operating income: -31938857.14285714
Net income: -25076714.285714287
Capital expenditures: 1144857.142857143
Operating cash flow: -21541285.714285713
Depreciation & amortization: 2144285.714285714
Net tangible assets: 90929000
Owner earnings: -24077285.714285716
Return on net tangible assets (%): -26.479215337555363
Buffett classification: The Gruesome
Stock price: 17.64
Shares outstanding: 112922546
Book value: 102214285.7142857
P/B ratio: 19.4880167436478
Market cap (USD): 1991953711.44
Debt to equity: 0.3134297693920336
Current ratio: 2.449229394039878
Quick ratio: 2.2696255820994504
Interest coverage ratio: -42.920330197734685
COGS to revenue (%): 38.27698385035436
R&D to revenue (%): 44.25107070027204
SG&A to revenue (%): 55.609307580437736
Free cash flow (dilution-adjusted): -32830142.85714286
Buyback yield (%): 0
Retained earnings: -375517142.85714287
Inventory turnover: 2.5564385577630606
Receivables turnover: 4.2203660650124695
Capitalized R&D asset: 65420549.127630934
ROCI (R&D-adjusted, %): -19.64399185022156
Rosenberg metric: 0.12570696326836953
FCF margin (%): -46.035304062851814
Revenue growth (%): 22.42827814122339
Rule of 40 score: -23.607025921628424
Financial ratios for ZLAB — quarterly report dated 2025-12-31
Total revenue: 20111000
Gross profit: 9323714.285714285
Operating income: -9752000
Net income: -7201285.714285715
Capital expenditures: 96428.57142857143
Operating cash flow: -3717428.5714285714
Depreciation & amortization: 559428.5714285715
Net tangible assets: 90929000
Owner earnings: -6738285.714285715
Return on net tangible assets (%): -7.410491388100292
Buffett classification: The Gruesome
Stock price: 17.64
Shares outstanding: 112922546
Book value: 102214285.7142857
P/B ratio: 19.4880167436478
Market cap (USD): 1991953711.44
Debt to equity: 0.3134297693920336
Current ratio: 2.449229394039878
Quick ratio: 2.2696255820994504
Interest coverage ratio: -50.15723732549596
COGS to revenue (%): 44.27640878836742
R&D to revenue (%): 43.78058915874042
SG&A to revenue (%): 51.882764940295644
Free cash flow (dilution-adjusted): -6174571.428571429
Buyback yield (%): 0
Retained earnings: -375517142.85714287
Inventory turnover: 0.8339153120610073
Receivables turnover: 1.190150906708374
Capitalized R&D asset: 15644307.581751142
ROCI (R&D-adjusted, %): -6.855892391031516
Rosenberg metric: -0.058987528912416244
FCF margin (%): -30.702458498192183
Revenue growth (%): 12.010075330303438
Rule of 40 score: -18.692383167888742
Financial ratios for 2498.HK — annual report dated 2022-12-31
Total revenue: 76195689.65517241
Gross profit: -5645833.333333333
Operating income: -81961925.28735632
Net income: -299728879.3103448
Capital expenditures: 15553591.954022989
Operating cash flow: -75154022.98850575
Depreciation & amortization: 7690373.563218391
Net tangible assets: -732712068.9655173
Owner earnings: -307592097.7011494
Buffett classification: The Gruesome
Shares outstanding: 462006584
Book value: -723743965.5172415
Debt to equity: -0.006056271090343198
Current ratio: 0.3615814050307862
Quick ratio: 0.3270761822438373
Interest coverage ratio: -187.64967105263156
COGS to revenue (%): 107.40964923197606
R&D to revenue (%): 57.6896677867409
SG&A to revenue (%): 48.222212165439124
Free cash flow (dilution-adjusted): -97488218.3908046
Retained earnings: -674138649.4252874
Inventory turnover: 1.9703930982953288
Receivables turnover: 2.5621524473024353
Capitalized R&D asset: 43957040.22988506
FCF margin (%): -127.94453181274774
Rule of 40 score: -127.94453181274774
Financial ratios for 2498.HK — annual report dated 2023-12-31
Total revenue: 157545569.62025315
Gross profit: 13170182.841068916
Operating income: -130861322.08157524
Net income: -609137271.4486638
Capital expenditures: 17439381.153305203
Operating cash flow: -72640928.2700422
Depreciation & amortization: 12518143.459915612
Net tangible assets: -1285122644.1631505
Owner earnings: -614058509.1420534
Buffett classification: The Gruesome
Shares outstanding: 462006584
Book value: -1275645428.973277
Debt to equity: -0.0018218625490485554
Current ratio: 0.2308164468484005
Quick ratio: 0.21454965018519603
Interest coverage ratio: -440.1248817407758
COGS to revenue (%): 91.64039783993023
R&D to revenue (%): 56.69888559468428
SG&A to revenue (%): 38.562102006072415
Free cash flow (dilution-adjusted): -146203516.17440224
Retained earnings: -1269907735.583685
Inventory turnover: 5.152873084317633
Receivables turnover: 1.6658323741199774
Capitalized R&D asset: 118777799.232504
Rosenberg metric: 0.42805466601024267
FCF margin (%): -92.80077918205525
Revenue growth (%): 106.76441191520661
Rule of 40 score: 13.963632733151357
Financial ratios for 5016.T — annual report dated 2022-03-31
Capital expenditures: 0
Net tangible assets: 3612612686.444845
Buffett classification: The Gruesome
Shares outstanding: 928462870
Book value: 4563940337.649565
Debt to equity: 1.1611263943457621
Current ratio: 1.1302653070978153
Quick ratio: 0.34219751982704577
Retained earnings: 2695566300.606458
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5016.T — annual report dated 2023-03-31
Total revenue: 12300930930.930931
Gross profit: 1821118618.6186187
Operating income: 229677177.1771772
Net income: 377672672.6726727
Capital expenditures: 535900900.90090096
Operating cash flow: 272154654.6546547
Depreciation & amortization: 500262762.7627628
Net tangible assets: 3449354354.354355
Owner earnings: 342034534.5345346
Return on net tangible assets (%): 9.91590017716681
Capex to operating income (%): 233.32788546399505
Buffett classification: The Gruesome
Shares outstanding: 928462870
Book value: 4523213213.213213
Debt to equity: 1.1932374205798586
Current ratio: 1.3678563620404038
Quick ratio: 0.7016588587582543
Effective tax rate (%): 20.561529837194247
Interest coverage ratio: 2.6179188772890636
COGS to revenue (%): 85.19527807412219
SG&A to revenue (%): 7.495221192272858
Free cash flow (dilution-adjusted): -265570570.5705706
Retained earnings: 2580202702.702703
Inventory turnover: 2.279112787356322
Receivables turnover: 8.308573862599134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.353796906346266
FCF margin (%): -2.1589469289904573
Rule of 40 score: -2.1589469289904573
Financial ratios for 5016.T — annual report dated 2024-03-31
Total revenue: 9986430269.41363
Gross profit: 1145034337.0311675
Operating income: 205104331.7485473
Net income: 758630480.7184364
Capital expenditures: 555824088.748019
Operating cash flow: 253565768.62123615
Depreciation & amortization: 258174854.72794506
Net tangible assets: 3921922873.7453775
Owner earnings: 460981246.69836247
Return on net tangible assets (%): 11.753960022628704
Capex to operating income (%): 270.9957824925147
Buffett classification: The Gruesome
Shares outstanding: 928462870
Book value: 4759653988.378235
Debt to equity: 0.5390245865022573
Current ratio: 1.470938525384033
Quick ratio: 0.7226627847596018
Effective tax rate (%): -45.95497624310796
Interest coverage ratio: 2.9322193901633153
COGS to revenue (%): 88.53409770918672
SG&A to revenue (%): 6.968780271697265
Free cash flow (dilution-adjusted): -303902535.65768623
Retained earnings: 2951300845.2192287
Inventory turnover: 5.251634589362128
Receivables turnover: 13.87892664751714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1528856704640154
FCF margin (%): -3.0431548357021714
Revenue growth (%): -18.81565447780415
Rule of 40 score: -21.85880931350632
Financial ratios for 5016.T — quarterly report dated 2024-12-31
Total revenue: 1145996560.2904644
Gross profit: 245735397.1590547
Operating income: 47334225.109879605
Net income: 61710937.002356835
Capital expenditures: 90107650.16880056
Operating cash flow: 359016497.8661061
Depreciation & amortization: 79476399.77068603
Net tangible assets: 3671291165.0423594
Owner earnings: 51079686.604242295
Return on net tangible assets (%): 1.3913275822581874
Capex to operating income (%): 190.3646884672319
Buffett classification: The Gruesome
Shares outstanding: 928462870
Book value: 4467278170.584114
Debt to equity: 0.4588931126821213
Current ratio: 1.6942341272490278
Quick ratio: 0.7201982973969077
Effective tax rate (%): 42.85714285714286
Interest coverage ratio: 4.278065630397236
COGS to revenue (%): 78.55705630593074
SG&A to revenue (%): 13.481740870435216
Free cash flow (dilution-adjusted): 268819670.0426779
Retained earnings: 2603675393.337155
Inventory turnover: 0.5097950099735602
Receivables turnover: 1.4553823503239847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.763482697577219
FCF margin (%): 23.45728419765438
Rule of 40 score: 23.45728419765438
Financial ratios for 5247.T — annual report dated 2022-03-31
Total revenue: 24927528.274053436
Gross profit: 3975536.7972463532
Operating income: 565948.2052122602
Net income: 537370.922799541
Capital expenditures: 8474.020652352074
Operating cash flow: 624741.8455990822
Depreciation & amortization: 35682.67497131618
Net tangible assets: 1127241.4358301917
Owner earnings: 564579.5771185051
Return on net tangible assets (%): 50.0850624518343
Capex to operating income (%): 1.4973138132267547
Buffett classification: The Great
Shares outstanding: 2816842
Book value: 1127241.4358301917
Debt to equity: 2.83262326785221
Current ratio: 1.8550602159842788
Quick ratio: 1.8475309643571853
Effective tax rate (%): 2.0260881258684833
Interest coverage ratio: 13.022251555723175
COGS to revenue (%): 84.05158767079918
Free cash flow (dilution-adjusted): 616267.82494673
Retained earnings: 509768.89034584496
Inventory turnover: 765.2083208620174
Receivables turnover: 6.841733884572648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.38370763325093
FCF margin (%): 2.4722379939618437
Rule of 40 score: 2.4722379939618437
Financial ratios for ABT.TO — annual report dated 2022-12-31
Total revenue: 32097794117.647057
Gross profit: 18022794117.647057
Operating income: 6148529411.764706
Net income: 5097794117.6470585
Capital expenditures: 1306617647.0588233
Operating cash flow: 7044852941.17647
Depreciation & amortization: 2402205882.352941
Net tangible assets: 2524264705.882353
Owner earnings: 6193382352.941176
Return on net tangible assets (%): 245.35391785610253
Capex to operating income (%): 21.250896914613726
Buffett classification: The Great
Shares outstanding: 13388659235
Book value: 27136029411.7647
Debt to equity: 0.4800433545590029
Current ratio: 1.6285105558783655
Quick ratio: 1.2299696558848217
Effective tax rate (%): 16.530219118709365
Interest coverage ratio: 14.985663082437277
COGS to revenue (%): 43.85036538153162
R&D to revenue (%): 6.615811055368474
SG&A to revenue (%): 25.766843057750897
Free cash flow (dilution-adjusted): 5234558823.529411
Retained earnings: 25924264705.88235
Inventory turnover: 3.1009233759922243
Receivables turnover: 4.9153248508050895
Capitalized R&D asset: 2123529411.7647057
ROCI (R&D-adjusted, %): 16.63621025168319
FCF margin (%): 16.30815751494743
Rule of 40 score: 16.30815751494743
Financial ratios for ABT.TO — annual report dated 2023-12-31
Total revenue: 30385606060.60606
Gross profit: 16768181818.181818
Operating income: 4907575757.575757
Net income: 4335606060.60606
Capital expenditures: 1668181818.181818
Operating cash flow: 5500757575.757575
Depreciation & amortization: 2456818181.8181815
Net tangible assets: 4628030303.030303
Owner earnings: 5124242424.242424
Return on net tangible assets (%): 110.72188574234735
Capex to operating income (%): 33.99197283112071
Buffett classification: The Good
Shares outstanding: 13388659235
Book value: 29414393939.393936
Debt to equity: 0.40250341257372446
Current ratio: 1.6378874358789106
Quick ratio: 1.1632107506683043
Effective tax rate (%): 14.120648259303723
Interest coverage ratio: 10.169544740973311
COGS to revenue (%): 44.815378094691965
R&D to revenue (%): 6.833877683312972
SG&A to revenue (%): 27.298112643047695
Free cash flow (dilution-adjusted): 3344696969.6969695
Retained earnings: 28450000000
Inventory turnover: 2.7359208523592087
Receivables turnover: 4.546990137172656
Capitalized R&D asset: 3499279857.3975043
ROCI (R&D-adjusted, %): 11.518587793191905
Rosenberg metric: -0.5908146562578687
FCF margin (%): 11.007504550100974
Revenue growth (%): -5.334285748003014
Rule of 40 score: 5.67321880209796
Financial ratios for ABT.TO — annual report dated 2024-12-31
Total revenue: 29335664335.664337
Gross profit: 16254545454.545456
Operating income: 4772727272.727273
Net income: 9372027972.027973
Capital expenditures: 1543356643.3566434
Operating cash flow: 5984615384.615385
Depreciation & amortization: 2250349650.3496504
Net tangible assets: 12523776223.776224
Owner earnings: 10079020979.02098
Return on net tangible assets (%): 80.47908872633872
Capex to operating income (%): 32.336996336996336
Buffett classification: The Good
Shares outstanding: 13388659235
Book value: 33497202797.202797
Debt to equity: 0.31358426755182567
Current ratio: 1.6709754891573074
Quick ratio: 1.2334534152715972
Effective tax rate (%): -91.10223869955794
Interest coverage ratio: 12.209302325581396
COGS to revenue (%): 44.591179976162095
R&D to revenue (%): 6.779499404052443
SG&A to revenue (%): 27.883194278903456
Free cash flow (dilution-adjusted): 3970629370.6293707
Retained earnings: 33049650349.650352
Inventory turnover: 3.0200193735873424
Receivables turnover: 4.418114797261717
Capitalized R&D asset: 4080841046.2086935
ROCI (R&D-adjusted, %): 9.192419629805332
Rosenberg metric: -0.24735497993432978
FCF margin (%): 13.535160905840286
Revenue growth (%): -3.455391749789509
Rule of 40 score: 10.079769156050777
Financial ratios for ABT.TO — quarterly report dated 2025-03-31
Total revenue: 7243356643.356644
Gross profit: 4118881118.8811193
Operating income: 1183916083.916084
Net income: 926573426.5734266
Capital expenditures: 338461538.4615385
Operating cash flow: 990909090.909091
Depreciation & amortization: 528671328.6713287
Net tangible assets: 13420279720.27972
Owner earnings: 1116783216.7832167
Return on net tangible assets (%): 8.321609087593142
Capex to operating income (%): 28.588304784406375
Buffett classification: The Good
Shares outstanding: 13388659235
Book value: 34310489510.48951
Debt to equity: 0.2698923854557313
Current ratio: 1.7804521685635188
Quick ratio: 1.2699169486311903
Effective tax rate (%): 25.478065241844767
Interest coverage ratio: 12.923664122137405
COGS to revenue (%): 43.13574049044217
R&D to revenue (%): 6.912531376713652
SG&A to revenue (%): 29.552037072793976
Free cash flow (dilution-adjusted): 450349650.3496503
Retained earnings: 33367132867.13287
Inventory turnover: 0.6729929206205754
Receivables turnover: 1.071147880041365
Capitalized R&D asset: 500699300.6993007
ROCI (R&D-adjusted, %): 3.138133796028533
FCF margin (%): 6.21741648966982
Rule of 40 score: 6.21741648966982
Financial ratios for ABT.TO — quarterly report dated 2025-06-30
Total revenue: 8132846715.328466
Gross profit: 4589781021.89781
Operating income: 1497810218.978102
Net income: 1298540145.9854014
Capital expenditures: 366423357.66423357
Operating cash flow: 1494160583.9416058
Depreciation & amortization: 567153284.6715328
Net tangible assets: 15104379562.043795
Owner earnings: 1499270072.9927006
Return on net tangible assets (%): 9.926061953317546
Capex to operating income (%): 24.46393762183236
Buffett classification: The Great
Shares outstanding: 13388659235
Book value: 37101459854.0146
Debt to equity: 0.2643569615770524
Current ratio: 1.820671180891435
Quick ratio: 1.303221965920083
Effective tax rate (%): 17.25581395348837
Interest coverage ratio: 16.958677685950413
COGS to revenue (%): 43.564889606892834
R&D to revenue (%): 6.506910788009335
SG&A to revenue (%): 27.74187758032669
Free cash flow (dilution-adjusted): 1024087591.2408757
Retained earnings: 35377372262.77372
Inventory turnover: 0.6980155306298532
Receivables turnover: 1.0889366692728695
Capitalized R&D asset: 864665611.7605023
ROCI (R&D-adjusted, %): 3.215128265386189
Rosenberg metric: 0.9404844431757929
FCF margin (%): 12.591994255968405
Revenue growth (%): 12.280081124924758
Rule of 40 score: 24.872075380893165
Financial ratios for ABT.TO — quarterly report dated 2025-09-30
Total revenue: 8179136690.647483
Gross profit: 4528057553.956835
Operating income: 1479856115.1079137
Net income: 1182733812.9496403
Capital expenditures: 356834532.37410074
Operating cash flow: 2005035971.2230217
Depreciation & amortization: 569064748.2014389
Net tangible assets: 15387769784.172663
Owner earnings: 1394964028.7769785
Return on net tangible assets (%): 9.065407452428818
Capex to operating income (%): 24.112785610111814
Buffett classification: The Great
Shares outstanding: 13388659235
Book value: 36880575539.56835
Debt to equity: 0.2524383583021223
Current ratio: 1.703401453847209
Quick ratio: 1.24338225209162
Effective tax rate (%): 24.587155963302752
Interest coverage ratio: 17
COGS to revenue (%): 44.63893042483947
R&D to revenue (%): 6.737619843433898
SG&A to revenue (%): 26.836133345061132
Free cash flow (dilution-adjusted): 1561870503.5971224
Retained earnings: 35325899280.57554
Inventory turnover: 0.7565593321407275
Receivables turnover: 1.0933833429505675
Capitalized R&D asset: 1070871949.7170372
ROCI (R&D-adjusted, %): 2.940715301974326
Rosenberg metric: -0.11663607045398071
FCF margin (%): 19.095786788635763
Revenue growth (%): 0.5691730944808163
Rule of 40 score: 19.66495988311658
Financial ratios for ABVE — annual report dated 2022-01-31
Total revenue: 155357588.28125
Gross profit: 6181737.5
Operating income: -3021722.65625
Net income: -4513467.1875
Capital expenditures: 17186202.34375
Operating cash flow: -21542847.65625
Depreciation & amortization: 1067245.3125
Net tangible assets: 22722741.40625
Owner earnings: -20632424.21875
Return on net tangible assets (%): -90.80077024982096
Buffett classification: The Gruesome
Shares outstanding: 51191848
Book value: 25144124.21875
Debt to equity: 2.6302548194115554
Current ratio: 1.0601129974162615
Quick ratio: 0.5581522732204355
Interest coverage ratio: -1.8539295413737602
COGS to revenue (%): 96.02096198300339
R&D to revenue (%): 0.11822272138873487
SG&A to revenue (%): 5.446703995836461
Free cash flow (dilution-adjusted): -38835278.125
Retained earnings: -3971442.1875
Inventory turnover: 3.7891702075333975
Receivables turnover: 7.316474649003122
Capitalized R&D asset: 183667.96875
ROCI (R&D-adjusted, %): -5.214923434920125
FCF margin (%): -24.997348732457763
Rule of 40 score: -24.997348732457763
Financial ratios for ABVE — annual report dated 2023-01-31
Total revenue: 295869032.83582085
Gross profit: -954955.2238805969
Operating income: -23669226.119402982
Net income: -33943679.10447761
Capital expenditures: 1782254.4776119401
Operating cash flow: -13340972.3880597
Depreciation & amortization: 2208221.6417910447
Net tangible assets: -229374.62686567163
Owner earnings: -33517711.9402985
Buffett classification: The Gruesome
Shares outstanding: 51191848
Book value: 1963416.4179104567
Debt to equity: 43.94117396648678
Current ratio: 0.7261173480209879
Quick ratio: 0.3866363909222045
Interest coverage ratio: -5.896887456865778
COGS to revenue (%): 100.32276281661777
R&D to revenue (%): 0.10862662247311808
SG&A to revenue (%): 6.9716601918037036
Free cash flow (dilution-adjusted): -20526952.23880597
Retained earnings: -37737295.522388056
Inventory turnover: 8.300240792956686
Receivables turnover: 11.103052582239748
Capitalized R&D asset: 444450.07637593284
ROCI (R&D-adjusted, %): -78.13562727675622
Rosenberg metric: -38.85649072318494
FCF margin (%): -6.937850859909517
Revenue growth (%): 90.44388890756814
Rule of 40 score: 83.50603804765862
Financial ratios for BBCQ — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -166
Buffett classification: The Gruesome
Shares outstanding: 28750000
Book value: -166
Debt to equity: -288.67469879518075
Current ratio: 0.21398163606010018
Quick ratio: 0.21398163606010018
Retained earnings: -25166
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBCQ — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: -37576
Buffett classification: The Gruesome
Shares outstanding: 28750000
Book value: -37576
Debt to equity: -6.60030338513945
Current ratio: 0.01737912189699889
Quick ratio: 0.01737912189699889
Retained earnings: -62576
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSCO.TO — annual report dated 2022-07-31
Total revenue: 40278906250
Gross profit: 25193750000
Operating income: 10917968750
Net income: 9228125000
Capital expenditures: 372656250
Operating cash flow: 10332812500
Depreciation & amortization: 1528906250
Net tangible assets: -859375000
Owner earnings: 10384375000
Return on net tangible assets (%): -1208.3636363636365
Capex to operating income (%): 3.413237924865832
Buffett classification: The Great
Shares outstanding: 11542953619
Book value: 31072656250
Debt to equity: 0.23923264526186105
Current ratio: 1.4320202808112326
Quick ratio: 1.3318642745709828
Effective tax rate (%): 18.408510050424812
Interest coverage ratio: 38.81944444444444
COGS to revenue (%): 37.45175242935004
R&D to revenue (%): 13.138856023430378
SG&A to revenue (%): 21.69637488604845
Free cash flow (dilution-adjusted): 8486718750
Retained earnings: -1030468750
Inventory turnover: 7.519080996884735
Receivables turnover: 4.897596656217346
Capitalized R&D asset: 5292187500
ROCI (R&D-adjusted, %): 24.61004045996593
FCF margin (%): 21.069883817910274
Rule of 40 score: 21.069883817910274
Financial ratios for CSCO.TO — annual report dated 2023-07-31
Total revenue: 42855639097.74436
Gross profit: 26881954887.218044
Operating income: 11700751879.699247
Net income: 9483458646.61654
Capital expenditures: 638345864.6616541
Operating cash flow: 14951879699.24812
Depreciation & amortization: 1297744360.9022555
Net tangible assets: 3007518796.992481
Owner earnings: 10142857142.857143
Return on net tangible assets (%): 337.25
Capex to operating income (%): 5.455596966970826
Buffett classification: The Great
Shares outstanding: 11542953619
Book value: 33348120300.751884
Debt to equity: 0.18918675174170851
Current ratio: 1.384522022421668
Quick ratio: 1.268133763454598
Effective tax rate (%): 17.658963311137224
Interest coverage ratio: 36.44496487119438
COGS to revenue (%): 37.273237657461664
R&D to revenue (%): 13.247833257307274
SG&A to revenue (%): 21.6814625074564
Free cash flow (dilution-adjusted): 12544360902.255638
Retained earnings: 1232330827.0676692
Inventory turnover: 5.830131723380901
Receivables turnover: 6.191396915055399
Capitalized R&D asset: 9223209234.022556
ROCI (R&D-adjusted, %): 22.038190923112673
Rosenberg metric: 0.3189994472452165
FCF margin (%): 29.27120249833327
Revenue growth (%): 6.397226458313679
Rule of 40 score: 35.66842895664695
Financial ratios for CSCO.TO — annual report dated 2024-07-31
Total revenue: 38987681159.420296
Gross profit: 25237681159.42029
Operating income: 9398550724.637682
Net income: 7478260869.565218
Capital expenditures: 485507246.3768116
Operating cash flow: 7884057971.014493
Depreciation & amortization: 1816666666.6666667
Net tangible assets: -17697101449.275364
Owner earnings: 8809420289.855072
Return on net tangible assets (%): -49.77888788796986
Capex to operating income (%): 5.165767154973015
Buffett classification: The Great
Shares outstanding: 11542953619
Book value: 32939855072.463768
Debt to equity: 0.6813692060628727
Current ratio: 0.9082889808791642
Quick ratio: 0.8251774098166765
Effective tax rate (%): 15.644923982344286
Interest coverage ratio: 12.892644135188867
COGS to revenue (%): 35.26755013660948
R&D to revenue (%): 14.837462595022583
SG&A to revenue (%): 24.491199375499505
Free cash flow (dilution-adjusted): 5171014492.753624
Retained earnings: 787681159.4202899
Inventory turnover: 5.62555588496887
Receivables turnover: 5.367953706475108
Capitalized R&D asset: 11335091701.740767
ROCI (R&D-adjusted, %): 13.316356414577218
Rosenberg metric: -0.28961515798847975
FCF margin (%): 13.263200936750739
Revenue growth (%): -9.025551875453539
Rule of 40 score: 4.2376490612971995
Financial ratios for DAIC — annual report dated 2022-12-31
Total revenue: 591751
Gross profit: 443191
Operating income: -841165
Net income: -968230
Capital expenditures: 254857
Operating cash flow: -877362
Net tangible assets: -1330255
Owner earnings: -1223087
Buffett classification: The Gruesome
Shares outstanding: 1210383
Book value: -1075398
Debt to equity: 0
Current ratio: 18.63603917991831
Quick ratio: 18.63603917991831
Interest coverage ratio: -95.53265190232823
COGS to revenue (%): 25.105154025933206
R&D to revenue (%): 120.42092028572829
SG&A to revenue (%): 96.62239692032628
Free cash flow (dilution-adjusted): -1167700
Retained earnings: -1255916
Receivables turnover: 5.246670686078059
Capitalized R&D asset: 712592
ROCI (R&D-adjusted, %): -19.71579949791005
FCF margin (%): -197.32962005978868
Rule of 40 score: -197.32962005978868
Financial ratios for DAIC — annual report dated 2023-12-31
Total revenue: 439640
Gross profit: 352752
Operating income: -1676678
Net income: -1939917
Capital expenditures: 672319
Operating cash flow: -1668503
Net tangible assets: -3880674
Owner earnings: -2612236
Buffett classification: The Gruesome
Shares outstanding: 1210383
Book value: -2953498
Debt to equity: 0
Current ratio: 17.375541297299748
Quick ratio: 17.375541297299748
COGS to revenue (%): 19.763442816850148
R&D to revenue (%): 190.48607951960693
SG&A to revenue (%): 271.1256937494313
Free cash flow (dilution-adjusted): -2402639
Retained earnings: -3195833
Receivables turnover: 92.0133947258267
Capitalized R&D asset: 1314889.6400000001
ROCI (R&D-adjusted, %): -45.74056675419729
Rosenberg metric: -0.12691554213350698
FCF margin (%): -546.5014557365117
Revenue growth (%): -25.705237506991963
Rule of 40 score: -572.2066932435037
Financial ratios for DAIC — quarterly report dated 2024-12-31
Capital expenditures: 254893
Net tangible assets: -26055318
Buffett classification: The Gruesome
Shares outstanding: 1210383
Book value: -24293922
Debt to equity: -0.01241619200061645
Current ratio: 0.4522781355471845
Quick ratio: 0.4228882433674777
Retained earnings: -24733263
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAIC — annual report dated 2024-12-31
Total revenue: 172661
Gross profit: 129027
Operating income: -5006543
Net income: -21537430
Capital expenditures: 0
Operating cash flow: -3290008
Depreciation & amortization: 0
Net tangible assets: -26055318
Owner earnings: -21537430
Buffett classification: The Gruesome
Shares outstanding: 1210383
Book value: -24293922
Debt to equity: -0.01241619200061645
Current ratio: 0.4522781355471845
Quick ratio: 0.4228882433674777
COGS to revenue (%): 25.271485743740623
R&D to revenue (%): 492.4453119117809
SG&A to revenue (%): 2481.9206421832378
Free cash flow (dilution-adjusted): -4321234
Retained earnings: -24733263
Inventory turnover: 0.6687408043158412
Receivables turnover: 3.4350827630113003
Capitalized R&D asset: 1646509.87
ROCI (R&D-adjusted, %): -196.43255468008354
Rosenberg metric: -0.2671493206185899
FCF margin (%): -2502.727309583519
Revenue growth (%): -60.72673096169593
Rule of 40 score: -2563.454040545215
Financial ratios for DAIC — quarterly report dated 2025-03-31
Total revenue: 352498
Gross profit: 335420
Operating income: -1358924
Net income: -1284558
Capital expenditures: 278413
Operating cash flow: -1721469
Depreciation & amortization: 0
Owner earnings: -1562971
Buffett classification: The Gruesome
Shares outstanding: 1210383
Interest coverage ratio: -8.493275
COGS to revenue (%): 4.84485018354714
R&D to revenue (%): 111.73510204313214
SG&A to revenue (%): 368.93258968845214
Free cash flow (dilution-adjusted): -2009887
Capitalized R&D asset: 393864
ROCI (R&D-adjusted, %): -278.35699632360405
FCF margin (%): -570.1839443060669
Rule of 40 score: -570.1839443060669
Financial ratios for KGS — annual report dated 2022-12-31
Total revenue: 707913000
Gross profit: 266099000
Operating income: 221217000
Net income: 106265000
Capital expenditures: 251267000
Operating cash flow: 219846000
Depreciation & amortization: 174463000
Net tangible assets: -208822000
Owner earnings: 29461000
Return on net tangible assets (%): -14.108187834615126
Capex to operating income (%): 113.58394698418294
Buffett classification: The Gruesome
Shares outstanding: 100918914
Book value: 229093000
Debt to equity: 11.91595989401684
Current ratio: 1.0796987945431646
Quick ratio: 0.6978737815784182
Effective tax rate (%): 23.746205788012084
Interest coverage ratio: 1.3337010978675685
COGS to revenue (%): 62.41077646546963
SG&A to revenue (%): 6.340044610001512
Free cash flow (dilution-adjusted): -40474000
Retained earnings: 195314000
Inventory turnover: 6.123123830642367
Receivables turnover: 7.001691294285205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.333404937932736
FCF margin (%): -5.717369224749369
Rule of 40 score: -5.717369224749369